Mct1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma

AuthID
P-00V-7MZ
Document Type
Article
Year published
2021
Published
in CANCERS
Volume: 13, Issue: 14
Indexing
Publication Identifiers
Wos: WOS:000676251800001
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.